NO884399L - Hjertebeskyttende middel. - Google Patents

Hjertebeskyttende middel. Download PDF

Info

Publication number
NO884399L
NO884399L NO88884399A NO884399A NO884399L NO 884399 L NO884399 L NO 884399L NO 88884399 A NO88884399 A NO 88884399A NO 884399 A NO884399 A NO 884399A NO 884399 L NO884399 L NO 884399L
Authority
NO
Norway
Prior art keywords
alkyl
substituted
compound
lower alkyl
nitro
Prior art date
Application number
NO88884399A
Other languages
English (en)
Norwegian (no)
Other versions
NO884399D0 (no
Inventor
Takao Takaya
Hisashi Takasugi
Kimio Esumi
Atsushi Kuno
Hiroyoshi Sakai
Kazuhiro Maeda
Yoshie Sakamoto
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/184,195 external-priority patent/US4857527A/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of NO884399D0 publication Critical patent/NO884399D0/no
Priority claimed from HU885132A external-priority patent/HUT51614A/hu
Publication of NO884399L publication Critical patent/NO884399L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO88884399A 1987-10-05 1988-10-04 Hjertebeskyttende middel. NO884399L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP25177187 1987-10-05
US07/184,195 US4857527A (en) 1985-12-12 1988-04-21 Morpholine containing pyridine compounds, compositions and use
HU885132A HUT51614A (en) 1985-12-12 1988-10-04 Process for producing cardio-protective and suitable for treating ischemic illnesses pharmaceutical compositions containing nitriferous heterocyclic compounds as active agent as well as for producing the active agents

Publications (2)

Publication Number Publication Date
NO884399D0 NO884399D0 (no) 1988-10-04
NO884399L true NO884399L (no) 1989-04-06

Family

ID=27270050

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88884399A NO884399L (no) 1987-10-05 1988-10-04 Hjertebeskyttende middel.

Country Status (10)

Country Link
EP (1) EP0311322B1 (fr)
JP (1) JPH01207234A (fr)
CN (1) CN1041589A (fr)
AU (1) AU621067B2 (fr)
CA (1) CA1317296C (fr)
DE (1) DE3882476T2 (fr)
DK (1) DK554988A (fr)
ES (1) ES2058301T3 (fr)
FI (1) FI884418A7 (fr)
NO (1) NO884399L (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8905526D0 (en) * 1989-03-10 1989-04-19 Fujisawa Pharmaceutical Co N-containing heterocyclic compounds,processes for the preparation thereof and composition comprising the same
GB2266841A (en) * 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
US6384060B1 (en) 1997-12-11 2002-05-07 American Home Products Corporation 2,4,6-trisbstituted pyridines with estrogenic activity and methods for the solid phase synthesis thereof
US6503917B1 (en) 1998-12-10 2003-01-07 Wyeth, Five Giralda Farms 2,4,6-trisubstituted pyridines with estrogenic activity and methods for the solid phase synthesis thereof
EP2295060B1 (fr) * 2001-12-06 2018-10-31 Fibrogen, Inc. Traitement de conditions ischémiques ou hypoxiques
CN101664409A (zh) * 2001-12-06 2010-03-10 法布罗根股份有限公司 低氧诱导因子(HIF)α的稳定化
DK2298301T3 (en) * 2001-12-06 2018-10-01 Fibrogen Inc MEDICINALS FOR TREATMENT OF ANEMIA ASSOCIATED WITH Kidney Disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8530602D0 (en) * 1985-12-12 1986-01-22 Fujisawa Pharmaceutical Co Heterocyclic compounds

Also Published As

Publication number Publication date
DK554988D0 (da) 1988-10-04
DK554988A (da) 1989-04-06
FI884418A0 (fi) 1988-09-27
AU621067B2 (en) 1992-03-05
FI884418L (fi) 1989-04-06
AU2333888A (en) 1989-06-01
EP0311322A2 (fr) 1989-04-12
EP0311322A3 (en) 1990-11-22
CA1317296C (fr) 1993-05-04
DE3882476T2 (de) 1993-11-11
JPH01207234A (ja) 1989-08-21
FI884418A7 (fi) 1989-04-06
NO884399D0 (no) 1988-10-04
EP0311322B1 (fr) 1993-07-21
CN1041589A (zh) 1990-04-25
ES2058301T3 (es) 1994-11-01
DE3882476D1 (de) 1993-08-26

Similar Documents

Publication Publication Date Title
NO781935L (no) Fremgangsmaate ved fremstilling av fthalazinderivater
CZ301631B6 (cs) Ortho- a meta-substituované bisarylové slouceniny a farmaceutické prostredky, které je obsahují
JP6437456B2 (ja) ｛［１−シアノ−５−（４−クロロフェノキシ）−４−ヒドロキシ−イソキノリン−３−カルボニル］−アミノ｝−酢酸の結晶形態
US5670509A (en) Tocolytic oxytocin receptor antagonists
JPH0233031B2 (fr)
NO884399L (no) Hjertebeskyttende middel.
WO2003080556A1 (fr) Derive d'amine a fonction regulatrice des canaux potassiques, sa preparation et son utilisation
JPH0242053A (ja) アミノグアニジン誘導体およびそれらを有効成分として含有するメイラード反応阻害剤
BRPI0612283A2 (pt) 2-pirrolidinonas, 2-piperidinonas e dióxidos-1,1-isotiazolidinas substituìdas, seus usos como bloqueadoras do canal de potássio kv1.5 e preparações farmacêuticas compreendendo as mesmas
KR100281867B1 (ko) 3-(비스-치환페닐메틸렌)옥신돌유도체
CN116813691B (zh) 新的二肽类化合物及其用途
KR860000931B1 (ko) 궤양 치료제인 2-구아니디노-4-(2-치환된-아미노-4-이미다졸릴)-티아졸의 제조방법
JPH02204475A (ja) 酵素‐阻害アミノ酸誘導体およびその製法
UA70340C2 (en) Optically active 5,6-dihydro-5-[(1-piperidinyl)-meoptically active 5,6-dihydro-5-[(1-piperidinyl)-methyl-3-(3-pyridyl)-4h-1,2,4-oxadiazine, a method fthyl-3-(3-pyridyl)-4h-1,2,4-oxadiazine, a method for the treatment and prevention of vascular diseasor the treatment and prevention of vascular diseases and a pharmaceutical composition es and a pharmaceutical composition
US4857527A (en) Morpholine containing pyridine compounds, compositions and use
MXPA04006716A (es) Derivados de carboxamidina y su uso en el tratamiento de enfermedades vasculares.
US3708598A (en) Substituted 2,4-(omega-aminoalkoxy)phenyl imidazoles as cholesterol reducing agents
TWI378095B (en) Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals
NO179519B (no) Analogifremgangsmåte for fremstilling av 3-(1,2-benzisoksazol-3-yl)-4-pyridinaminer og derivater derav
SU1127529A3 (ru) Способ получени производных пиридина или их солей с фармацевтически приемлемой кислотой
US4990507A (en) N-containing heterocyclic compounds, and composition comprising the same
US4758563A (en) 3-alkoxy-2-aminopropyamines, cardiovascular compositions and use
US4356118A (en) Tryptophan derivatives
US4243672A (en) 5-Substituted 2-pyrroleglyoxylic acids, 5-substituted 2-pyrrolylglycines and derivatives thereof
NO152214B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-cyano-n`-(2-((4-metyl-5-imidazolyl)-metyltio)etyl-n"-alknylguanidiner